ST Jia'ang announced after market close on September 18 that the company and its responsible persons had received an Administrative Penalty Decision from the Shanghai Securities Regulatory Bureau. According to the decision, ST Jia'ang's 2023 accounting error correction announcement contained false records, understating total profit for 2021 by 23.5 million yuan; its 2024 annual report also contained false records, overstating total profit for 2024 by 23.5 million yuan. The Shanghai bureau ordered the company to rectify the issues, issued a warning, and imposed a fine of 4 million yuan. Ji Min, then chairman, was fined 1 million yuan; Ji Lin, then chairman and acting board secretary, later director, president and chief financial officer, was fined 2 million yuan; and Cao Yi, then director and chief financial officer, was fined 1 million yuan. The company and the three executives were fined a total of 8 million yuan. ST Jia'ang's main business covers the research, development, production and sale of health products, health foods and health product raw materials, as well as the operation and management of elderly medical care institutions. The company was placed under investigation by the China Securities Regulatory Commission on July 11, 2025 for suspected illegal information disclosure, received a prior notice of administrative penalty on July 31, 2026, and has been subject to other risk warnings since August 4, 2026 because of false records in financial indicators in its annual report. In the first half of this year, ST Jia'ang achieved operating revenue of 140 million yuan, down 7.15 percent year on year; net profit attributable to the parent company was negative 14 million yuan, swinging from profit to loss, and its share price has fallen by more than 40 percent since the start of the year.
Shanghai Jiaoda Onlly Co LtdST Jia'ang (Shanghai Jiaoda Onlly) and three executives fined 8 million yuan by the Shanghai Securities Regulatory Bureau for false records in its 2023 correction and 2024 annual report.
